These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23040717)

  • 1. Vocal cord paralysis as a manifestation of myasthenia gravis with anti-MuSK antibodies.
    Jiménez Caballero PE; Fermin Marrero JA; Trigo Bragado I; Casado Naranjo I
    Neurologia; 2014 May; 29(4):253-4. PubMed ID: 23040717
    [No Abstract]   [Full Text] [Related]  

  • 2. Vocal cord paralysis in myasthenia gravis with anti-MuSK antibodies.
    Hara K; Mashima T; Matsuda A; Tanaka K; Tomita M; Shiraishi H; Motomura M; Nishizawa M
    Neurology; 2007 Feb; 68(8):621-2. PubMed ID: 17310039
    [No Abstract]   [Full Text] [Related]  

  • 3. Mantle cell lymphoma and anti-MuSK-positive Myasthenia gravis.
    Bhatt A; Farooq MU; Chang HT
    Onkologie; 2011; 34(7):382-3. PubMed ID: 21734425
    [No Abstract]   [Full Text] [Related]  

  • 4. Dyspnoea due to vocal fold abduction paresis in anti-MuSK myasthenia gravis.
    Sylva M; van der Kooi AJ; Grolman W
    J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1083-4. PubMed ID: 18708570
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxysmal supraventricular tachycardia in anti-musk Myasthenia gravis: A case report.
    Di Giovanni M; Battisti C; Salvatore S; Tumminelli G; Vinciguerra C; Ruocco G; Federico A
    J Neurol Sci; 2016 Oct; 369():250-251. PubMed ID: 27653899
    [No Abstract]   [Full Text] [Related]  

  • 7. Myasthenia gravis patients with anti-MuSK antibodies.
    Zagar M; Vranjes D; Sostarko M; Vogrinc Z; Bilić E; Trbojević Cepe M
    Coll Antropol; 2009 Dec; 33(4):1151-4. PubMed ID: 20102061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy.
    Chan JW; Orrison WW
    Br J Ophthalmol; 2007 Jun; 91(6):842-3. PubMed ID: 17510484
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab in the treatment of MuSK antibody-positive myasthenia gravis.
    Stein B; Bird SJ
    J Clin Neuromuscul Dis; 2011 Mar; 12(3):163-4. PubMed ID: 21321497
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myasthenia gravis induced by autoantibodies against MuSK].
    Shigemoto K; Konishi T; Ohta M
    Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysautonomia as the Presenting Symptom in Anti-Muscle-Specific Kinase Antibody Myasthenia Gravis.
    Bekooij TJS; Gilhuis HJ; Dawson L; Niks EH
    J Neuromuscul Dis; 2020; 7(1):47-50. PubMed ID: 31868676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
    Guptill JT; Sanders DB; Evoli A
    Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure ocular anti-musk myasthenia under no immunosuppressive treatment.
    Zouvelou V; Papathanasiou A; Koros C; Rentzos M; Zambelis T; Stamboulis E
    Muscle Nerve; 2013 Sep; 48(3):464. PubMed ID: 23512700
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis.
    Plomp JJ; Huijbers MG; van der Maarel SM; Verschuuren JJ
    Ann N Y Acad Sci; 2012 Dec; 1275():114-22. PubMed ID: 23278586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-MuSK myasthenia gravis presenting with Epstein-Barr virus-associated mononucleosis and immune-mediated diabetes mellitus.
    Bhibhatbhan A; Kline G; Vincent A; Toth C
    Muscle Nerve; 2007 Aug; 36(2):264-6. PubMed ID: 17266132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-MuSK antibodies: correlation with myasthenia gravis severity.
    Bartoccioni E; Scuderi F; Minicuci GM; Marino M; Ciaraffa F; Evoli A
    Neurology; 2006 Aug; 67(3):505-7. PubMed ID: 16894117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis.
    O'carroll P; Bertorini TE; Jacob G; Mitchell CW; Graff J
    J Clin Neuromuscul Dis; 2009 Dec; 11(2):69-71. PubMed ID: 19955986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ocular form of myasthenia gravis with a high titer of anti-MuSK antibodies during a long-term follow-up.
    Hosaka A; Takuma H; Ohta K; Tamaoka A
    Intern Med; 2012; 51(21):3077-9. PubMed ID: 23124154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.